SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Repligen Corp (RGEN) -- Ignore unavailable to you. Want to Upgrade?


To: Curtis E. Bemis who wrote (216)2/12/2000 8:02:00 AM
From: Curtis E. Bemis  Read Replies (1) | Respond to of 395
 
More DD--Staying on top of the SEC filings--Looking for clues.

Still looking for news and clues as for the recent RGEN activity.
A SEC 13-G was filed yesterday and this filing
is required to indicate large holdings. This 13-G documents
the beneficial ownership of 1,916,000 shares of RGEN, 8.76%
of the outstanding at the time of the filing, by Wellington
Management Co., LLP.

So, over 25% of Repligen is now controlled by two entities.
Still no news or clues.